All articles by Sanjay Kumar – Page 2
-
BusinessDeadly fire in Indian chemical factory
Blaze killed 18 workers, mainly women, who were trapped inside SVS Aqua Technologies plant
-
NewsFunding body plans to revive research fortunes of India’s left behind universities
National Research Foundation aims to rejuvenate and transform the country’s research with well-funded five-year programme
-
BusinessDeadly Indian incidents highlight relaxed regulations
Concern over human and environmental cost of reforms aimed at ease of doing business
-
BusinessStyrene vapour leak in India kills 12
Hundreds of locals hospitalised and evacuated to escape discharge from LG Polymers plant
-
BusinessCoronavirus pandemic will disrupt international supply chains
Halted production and transport restrictions are straining industries that rely heavily on China for supplies
-
NewsFinancial woes have India’s scientists worried despite budget funding pledges
Fears voiced that the promised investment in research will not materialise once more
-
BusinessFormer Ranbaxy owners arrested for fraud
Singh brothers accused of misappropriation, as well as not paying previous fines relating to Ranbaxy’s takeover by Daiichi Sankyo
-
NewsIndia becomes world's largest emitter of sulfur dioxide
Greenpeace study reveals global sulfur dioxide hotspots
-
NewsAnother five years of Modi government leaves Indian scientists worried
Concerns raised that India is falling behind competitors like China and that the government’s commitment to science is weak
-
BusinessIndia moves to ban cocktail drugs
Government injunction on 328 fixed dose combinations is strongly opposed by manufacturers
-
BusinessIndia creates national drugs database to address supply and quality issues
Regulatory body takes steps to reform how it manages and monitors pharmaceuticals
-
BusinessIndian court seizes former Ranbaxy owners’ assets
Daiichi Sankyo inches closer to recovering money from Singh brothers
-
NewsBudget fails to impress Indian scientists
Figures show that funding for science has actually fallen as the nation’s economy has grown rapidly
-
BusinessIndia’s Intas bags UK and Irish generics
Teva sheds former Actavis business to satisfy competition requirements of its Allergan generics takeover
-
BusinessIndia hit hard by US regulatory sanctions
Data integrity issues have led to punitive measures, but companies are taking measures to improve
-
BusinessDaiichi Sankyo awarded damages from former Ranbaxy owners
Arbitration says Singh family withheld information about regulatory investigations during Ranbaxy takeover
-
BusinessIndian pharma under increased regulatory scrutiny
Import bans and tightened rules pose a significant challenge for companies
-
Business
Sun Pharma snares Ranbaxy in $4bn deal
Acquisition makes Sun biggest drug firm in India and fifth largest generics producer in the world
-
NewsScientists left unimpressed by Indian budget
7.5% funding boost for science and technology fails to offset cuts of more than 20% last year
-
FeatureIndia’s chemistry challenges
India’s climate, its vast population and extremely rapid development make it host to a unique set of challenges. Sanjay Kumar finds out how Indian chemists are developing home-grown solutions
- Previous Page
- Page1
- Page2
- Next Page